Cipla 031 150 mg Pill - red capsule/oblong
Pill with imprint Cipla 031 150 mg is Red, Capsule/Oblong and has been identified as Nilotinib 150 mg. It is supplied by Cipla USA, Inc.
Nilotinib is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Nilotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 031 150 mg
Nilotinib
- Imprint
- Cipla 031 150 mg
- Strength
- 150 mg
- Color
- Red (red opaque cap and red opaque body)
- Shape
- Capsule/Oblong (hard gelatin capsule)
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- Genvion Corporation
- National Drug Code (NDC)
- 69097-0031
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Scemblix
Scemblix (asciminib) is an oral kinase inhibitor that may be used to treat adults with a type of ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
More about nilotinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (40)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.